SCHEMBL6519154

SCHEMBL6519154

COc1ccc(Nc2ccc3c(=O)[nH]c4ncccc4c3c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 5/20 0.55
PARP1 P09874 1/20 0.55
CDC25B P30305 1/20 0.52
KDM4E B2RXH2 2/20 0.51
PTK6 Q13882 1/20 0.50
BRD4 O60885 1/20 0.48
PKM P14618 1/20 0.48
APP P05067 1/20 0.47
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
DYRK1A Q13627 1/20 0.45
HCAR2 Q8TDS4 1/20 0.45
ALDH1A1 P00352 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MAPT P10636 1/20 0.43
CCNB2 O95067 1/20 0.43
CDK1 P06493 1/20 0.43
CCNB1 P14635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6521162 0.90 AURKA (0.55) AURKAPARP1PTK6PKMNPC1
SCHEMBL3455031 0.86 PARP1 (0.56) AURKAPARP1CDC25BKDM4EPTK6
SCHEMBL6520467 0.86 AURKA (0.59) AURKAPARP1CDC25BAPPNPC1
SCHEMBL6517435 0.85 AURKA (0.67) AURKAPARP1CDC25BKDM4EBRD4
SCHEMBL6527186 0.85 MAPT (0.51) AURKAPARP1KDM4EBRD4PKM
SCHEMBL6522968 0.83 AURKA (0.59) AURKAPARP1CDC25BKDM4EALDH1A1
SCHEMBL6521479 0.83 CDK2 (0.50) AURKAPARP1BRD4PKMNPC1
SCHEMBL6520958 0.82 AURKA (0.55) AURKAPARP1BRD4NPC1RAB9A
SCHEMBL6525737 0.82 AURKA (0.55) AURKAPARP1NPC1RAB9AL3MBTL1
SCHEMBL6523440 0.82 AURKA (0.55) AURKAPARP1PTK6BRD4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
WO-2009108670-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK SERONO S.A. (CH) 2009-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MAP4K2, MAP3K20, MAP4K1 AURKA 538/4885PARP1 1693/4885CDC25B 787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.